DexCom rises after raising lower end of 2026 revenue forecast range
DXCM•DexCom raised the lower end of its 2026 revenue forecast to $5.20 billion from $5.18 billion, reported third-quarter revenue of $1.34 billion and authorized up to $1 billion in share repurchases. Shares rose 2.6% in extended trading.
1. Forecast and results
DexCom expects 2026 revenue of $5.20 billion to $5.25 billion, compared with its prior range of $5.18 billion to $5.25 billion. Third-quarter revenue was $1.34 billion, above analysts’ estimate of $1.327 billion, and the company announced a share repurchase authorization of up to $1 billion.
